Africa: HIV Deaths and New Infections Decline, But Not Fast Enough to Meet 2030 Targets

Africa: Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low – and Middle-Income Countries

Geneva — A pivotal moment in the fight to end AIDS — ensuring lifesaving innovation reaches those who need it most, wherever they live The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) today announced it has signed an access agreement with Gilead Sciences to procure lenacapavir, a long-acting injectable for HIV…

Read More
Africa: HIV Deaths and New Infections Decline, But Not Fast Enough to Meet 2030 Targets

Africa: How Global Fund Is Saving Lives From Malaria, TB, & HIV Across Africa

New York — In Gabú, Guinea-Bissau, a grandmother named N’beta hesitated. Her six-month-old grandson, Seco, was healthy, so why give him medicine? But community health workers Jamilia and Amadu gently explained that the medicine wasn’t for illness, but for protection. It was part of a seasonal malaria chemoprevention campaign designed to protect children during the…

Read More